ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Calcium Antagonists Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-6J1475
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Calcium Antagonists Market Insights and Forecast to 2028
BUY CHAPTERS

Global Calcium Antagonists Market Research Report 2025

Code: QYRE-Auto-6J1475
Report
July 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Aventis
Searle
Bayer
Astrazeneca plc
Knoll Pharmaceuticals
Wyeth-Ayerst
Novartis
Sanofi
Baiyunshan Pharmaceutical
South China Pharmaceutical Group
Tianjin Tanabe Seiyaku

Calcium Antagonists Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Calcium Antagonists Market

Calcium Antagonists Market

The global market for Calcium Antagonists was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Calcium antagonists are a group of medications that disrupt the movement of calcium (Ca2+) through calcium channels. Calcium channel blockers are used as antihypertensive drugs, i.e., as medications to decrease blood pressure in patients with hypertension. CCBs are particularly effective against large vessel stiffness, one of the common causes of elevated systolic blood pressure in elderly patients. Calcium channel blockers are also frequently used to alter heart rate (especially from atrial fibrillation), to prevent peripheral and cerebral vasospasm, and to reduce chest pain caused by angina pectoris.
N-type, L-type, and T-type voltage-dependent calcium channels are present in the zona glomerulosa of the human adrenal gland, and CCBs can directly influence the biosynthesis of aldosterone in adrenocortical cells, with consequent impact on the clinical treatment of hypertension with these agents.
CCBs have been shown to be slightly more effective than beta blockers at lowering cardiovascular mortality, but they are associated with more side effects. Potential major risks however were mainly found to be associated with short-acting CCBs.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Calcium Antagonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Calcium Antagonists.
The Calcium Antagonists market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Calcium Antagonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Calcium Antagonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Calcium Antagonists Market Report

Report Metric Details
Report Name Calcium Antagonists Market
CAGR 5%
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Aventis, Searle, Bayer, AstraZeneca, Knoll Pharmaceuticals, Wyeth-Ayerst, Novartis, Sanofi, Baiyunshan Pharmaceutical, South China Pharmaceutical Group, Tianjin Tanabe Seiyaku
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Calcium Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Calcium Antagonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Calcium Antagonists Market report?

Ans: The main players in the Calcium Antagonists Market are Pfizer, Aventis, Searle, Bayer, AstraZeneca, Knoll Pharmaceuticals, Wyeth-Ayerst, Novartis, Sanofi, Baiyunshan Pharmaceutical, South China Pharmaceutical Group, Tianjin Tanabe Seiyaku

What are the Application segmentation covered in the Calcium Antagonists Market report?

Ans: The Applications covered in the Calcium Antagonists Market report are Hypertension, Coronary Artery Disease, Arrhythmia, Ohers

What are the Type segmentation covered in the Calcium Antagonists Market report?

Ans: The Types covered in the Calcium Antagonists Market report are Dihydropyridine, Diltiazem, Verapamil, Others

Recommended Reports

Cardiovascular Drugs

Heart Failure & Arrhythmia

Calcium & Lipids Therapies

1 Calcium Antagonists Market Overview
1.1 Product Definition
1.2 Calcium Antagonists by Type
1.2.1 Global Calcium Antagonists Market Value Comparison by Type (2024 VS 2031)
1.2.2 Dihydropyridine
1.2.3 Diltiazem
1.2.4 Verapamil
1.2.5 Others
1.3 Calcium Antagonists by Application
1.3.1 Global Calcium Antagonists Market Value by Application (2024 VS 2031)
1.3.2 Hypertension
1.3.3 Coronary Artery Disease
1.3.4 Arrhythmia
1.3.5 Ohers
1.4 Global Calcium Antagonists Market Size Estimates and Forecasts
1.4.1 Global Calcium Antagonists Revenue 2020-2031
1.4.2 Global Calcium Antagonists Sales 2020-2031
1.4.3 Global Calcium Antagonists Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Calcium Antagonists Market Competition by Manufacturers
2.1 Global Calcium Antagonists Sales Market Share by Manufacturers (2020-2025)
2.2 Global Calcium Antagonists Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Calcium Antagonists Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Calcium Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Calcium Antagonists, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Calcium Antagonists, Product Type & Application
2.7 Global Key Manufacturers of Calcium Antagonists, Date of Enter into This Industry
2.8 Global Calcium Antagonists Market Competitive Situation and Trends
2.8.1 Global Calcium Antagonists Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Calcium Antagonists Players Market Share by Revenue
2.8.3 Global Calcium Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Calcium Antagonists Market Scenario by Region
3.1 Global Calcium Antagonists Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Calcium Antagonists Sales by Region: 2020-2031
3.2.1 Global Calcium Antagonists Sales by Region: 2020-2025
3.2.2 Global Calcium Antagonists Sales by Region: 2026-2031
3.3 Global Calcium Antagonists Revenue by Region: 2020-2031
3.3.1 Global Calcium Antagonists Revenue by Region: 2020-2025
3.3.2 Global Calcium Antagonists Revenue by Region: 2026-2031
3.4 North America Calcium Antagonists Market Facts & Figures by Country
3.4.1 North America Calcium Antagonists Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Calcium Antagonists Sales by Country (2020-2031)
3.4.3 North America Calcium Antagonists Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Calcium Antagonists Market Facts & Figures by Country
3.5.1 Europe Calcium Antagonists Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Calcium Antagonists Sales by Country (2020-2031)
3.5.3 Europe Calcium Antagonists Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Calcium Antagonists Market Facts & Figures by Region
3.6.1 Asia Pacific Calcium Antagonists Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Calcium Antagonists Sales by Region (2020-2031)
3.6.3 Asia Pacific Calcium Antagonists Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Calcium Antagonists Market Facts & Figures by Country
3.7.1 Latin America Calcium Antagonists Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Calcium Antagonists Sales by Country (2020-2031)
3.7.3 Latin America Calcium Antagonists Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Calcium Antagonists Market Facts & Figures by Country
3.8.1 Middle East and Africa Calcium Antagonists Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Calcium Antagonists Sales by Country (2020-2031)
3.8.3 Middle East and Africa Calcium Antagonists Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Calcium Antagonists Sales by Type (2020-2031)
4.1.1 Global Calcium Antagonists Sales by Type (2020-2025)
4.1.2 Global Calcium Antagonists Sales by Type (2026-2031)
4.1.3 Global Calcium Antagonists Sales Market Share by Type (2020-2031)
4.2 Global Calcium Antagonists Revenue by Type (2020-2031)
4.2.1 Global Calcium Antagonists Revenue by Type (2020-2025)
4.2.2 Global Calcium Antagonists Revenue by Type (2026-2031)
4.2.3 Global Calcium Antagonists Revenue Market Share by Type (2020-2031)
4.3 Global Calcium Antagonists Price by Type (2020-2031)
5 Segment by Application
5.1 Global Calcium Antagonists Sales by Application (2020-2031)
5.1.1 Global Calcium Antagonists Sales by Application (2020-2025)
5.1.2 Global Calcium Antagonists Sales by Application (2026-2031)
5.1.3 Global Calcium Antagonists Sales Market Share by Application (2020-2031)
5.2 Global Calcium Antagonists Revenue by Application (2020-2031)
5.2.1 Global Calcium Antagonists Revenue by Application (2020-2025)
5.2.2 Global Calcium Antagonists Revenue by Application (2026-2031)
5.2.3 Global Calcium Antagonists Revenue Market Share by Application (2020-2031)
5.3 Global Calcium Antagonists Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Calcium Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Calcium Antagonists Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Aventis
6.2.1 Aventis Company Information
6.2.2 Aventis Description and Business Overview
6.2.3 Aventis Calcium Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Aventis Calcium Antagonists Product Portfolio
6.2.5 Aventis Recent Developments/Updates
6.3 Searle
6.3.1 Searle Company Information
6.3.2 Searle Description and Business Overview
6.3.3 Searle Calcium Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Searle Calcium Antagonists Product Portfolio
6.3.5 Searle Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Company Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Calcium Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bayer Calcium Antagonists Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Company Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Calcium Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AstraZeneca Calcium Antagonists Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Knoll Pharmaceuticals
6.6.1 Knoll Pharmaceuticals Company Information
6.6.2 Knoll Pharmaceuticals Description and Business Overview
6.6.3 Knoll Pharmaceuticals Calcium Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Knoll Pharmaceuticals Calcium Antagonists Product Portfolio
6.6.5 Knoll Pharmaceuticals Recent Developments/Updates
6.7 Wyeth-Ayerst
6.7.1 Wyeth-Ayerst Company Information
6.7.2 Wyeth-Ayerst Description and Business Overview
6.7.3 Wyeth-Ayerst Calcium Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Wyeth-Ayerst Calcium Antagonists Product Portfolio
6.7.5 Wyeth-Ayerst Recent Developments/Updates
6.8 Novartis
6.8.1 Novartis Company Information
6.8.2 Novartis Description and Business Overview
6.8.3 Novartis Calcium Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Novartis Calcium Antagonists Product Portfolio
6.8.5 Novartis Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Company Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Calcium Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sanofi Calcium Antagonists Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 Baiyunshan Pharmaceutical
6.10.1 Baiyunshan Pharmaceutical Company Information
6.10.2 Baiyunshan Pharmaceutical Description and Business Overview
6.10.3 Baiyunshan Pharmaceutical Calcium Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Baiyunshan Pharmaceutical Calcium Antagonists Product Portfolio
6.10.5 Baiyunshan Pharmaceutical Recent Developments/Updates
6.11 South China Pharmaceutical Group
6.11.1 South China Pharmaceutical Group Company Information
6.11.2 South China Pharmaceutical Group Description and Business Overview
6.11.3 South China Pharmaceutical Group Calcium Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.11.4 South China Pharmaceutical Group Calcium Antagonists Product Portfolio
6.11.5 South China Pharmaceutical Group Recent Developments/Updates
6.12 Tianjin Tanabe Seiyaku
6.12.1 Tianjin Tanabe Seiyaku Company Information
6.12.2 Tianjin Tanabe Seiyaku Description and Business Overview
6.12.3 Tianjin Tanabe Seiyaku Calcium Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Tianjin Tanabe Seiyaku Calcium Antagonists Product Portfolio
6.12.5 Tianjin Tanabe Seiyaku Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Calcium Antagonists Industry Chain Analysis
7.2 Calcium Antagonists Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Calcium Antagonists Production Mode & Process Analysis
7.4 Calcium Antagonists Sales and Marketing
7.4.1 Calcium Antagonists Sales Channels
7.4.2 Calcium Antagonists Distributors
7.5 Calcium Antagonists Customer Analysis
8 Calcium Antagonists Market Dynamics
8.1 Calcium Antagonists Industry Trends
8.2 Calcium Antagonists Market Drivers
8.3 Calcium Antagonists Market Challenges
8.4 Calcium Antagonists Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Aventis
Searle
Bayer
Astrazeneca plc
Knoll Pharmaceuticals
Wyeth-Ayerst
Novartis
Sanofi
Baiyunshan Pharmaceutical
South China Pharmaceutical Group
Tianjin Tanabe Seiyaku
List of Tables
 Table 1. Global Calcium Antagonists Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Calcium Antagonists Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Calcium Antagonists Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Calcium Antagonists Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Calcium Antagonists Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Calcium Antagonists Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Calcium Antagonists Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Calcium Antagonists Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Calcium Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Calcium Antagonists, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Calcium Antagonists, Product Type & Application
 Table 12. Global Key Manufacturers of Calcium Antagonists, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Calcium Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Calcium Antagonists as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Calcium Antagonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Calcium Antagonists Sales by Region (2020-2025) & (K Units)
 Table 18. Global Calcium Antagonists Sales Market Share by Region (2020-2025)
 Table 19. Global Calcium Antagonists Sales by Region (2026-2031) & (K Units)
 Table 20. Global Calcium Antagonists Sales Market Share by Region (2026-2031)
 Table 21. Global Calcium Antagonists Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Calcium Antagonists Revenue Market Share by Region (2020-2025)
 Table 23. Global Calcium Antagonists Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Calcium Antagonists Revenue Market Share by Region (2026-2031)
 Table 25. North America Calcium Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Calcium Antagonists Sales by Country (2020-2025) & (K Units)
 Table 27. North America Calcium Antagonists Sales by Country (2026-2031) & (K Units)
 Table 28. North America Calcium Antagonists Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Calcium Antagonists Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Calcium Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Calcium Antagonists Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Calcium Antagonists Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Calcium Antagonists Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Calcium Antagonists Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Calcium Antagonists Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Calcium Antagonists Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Calcium Antagonists Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Calcium Antagonists Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Calcium Antagonists Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Calcium Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Calcium Antagonists Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Calcium Antagonists Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Calcium Antagonists Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Calcium Antagonists Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Calcium Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Calcium Antagonists Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Calcium Antagonists Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Calcium Antagonists Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Calcium Antagonists Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Calcium Antagonists Sales (K Units) by Type (2020-2025)
 Table 51. Global Calcium Antagonists Sales (K Units) by Type (2026-2031)
 Table 52. Global Calcium Antagonists Sales Market Share by Type (2020-2025)
 Table 53. Global Calcium Antagonists Sales Market Share by Type (2026-2031)
 Table 54. Global Calcium Antagonists Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Calcium Antagonists Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Calcium Antagonists Revenue Market Share by Type (2020-2025)
 Table 57. Global Calcium Antagonists Revenue Market Share by Type (2026-2031)
 Table 58. Global Calcium Antagonists Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Calcium Antagonists Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Calcium Antagonists Sales (K Units) by Application (2020-2025)
 Table 61. Global Calcium Antagonists Sales (K Units) by Application (2026-2031)
 Table 62. Global Calcium Antagonists Sales Market Share by Application (2020-2025)
 Table 63. Global Calcium Antagonists Sales Market Share by Application (2026-2031)
 Table 64. Global Calcium Antagonists Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Calcium Antagonists Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Calcium Antagonists Revenue Market Share by Application (2020-2025)
 Table 67. Global Calcium Antagonists Revenue Market Share by Application (2026-2031)
 Table 68. Global Calcium Antagonists Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Calcium Antagonists Price (USD/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Calcium Antagonists Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Aventis Company Information
 Table 76. Aventis Description and Business Overview
 Table 77. Aventis Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Aventis Calcium Antagonists Product
 Table 79. Aventis Recent Developments/Updates
 Table 80. Searle Company Information
 Table 81. Searle Description and Business Overview
 Table 82. Searle Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Searle Calcium Antagonists Product
 Table 84. Searle Recent Developments/Updates
 Table 85. Bayer Company Information
 Table 86. Bayer Description and Business Overview
 Table 87. Bayer Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Bayer Calcium Antagonists Product
 Table 89. Bayer Recent Developments/Updates
 Table 90. AstraZeneca Company Information
 Table 91. AstraZeneca Description and Business Overview
 Table 92. AstraZeneca Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. AstraZeneca Calcium Antagonists Product
 Table 94. AstraZeneca Recent Developments/Updates
 Table 95. Knoll Pharmaceuticals Company Information
 Table 96. Knoll Pharmaceuticals Description and Business Overview
 Table 97. Knoll Pharmaceuticals Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Knoll Pharmaceuticals Calcium Antagonists Product
 Table 99. Knoll Pharmaceuticals Recent Developments/Updates
 Table 100. Wyeth-Ayerst Company Information
 Table 101. Wyeth-Ayerst Description and Business Overview
 Table 102. Wyeth-Ayerst Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Wyeth-Ayerst Calcium Antagonists Product
 Table 104. Wyeth-Ayerst Recent Developments/Updates
 Table 105. Novartis Company Information
 Table 106. Novartis Description and Business Overview
 Table 107. Novartis Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Novartis Calcium Antagonists Product
 Table 109. Novartis Recent Developments/Updates
 Table 110. Sanofi Company Information
 Table 111. Sanofi Description and Business Overview
 Table 112. Sanofi Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Sanofi Calcium Antagonists Product
 Table 114. Sanofi Recent Developments/Updates
 Table 115. Baiyunshan Pharmaceutical Company Information
 Table 116. Baiyunshan Pharmaceutical Description and Business Overview
 Table 117. Baiyunshan Pharmaceutical Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Baiyunshan Pharmaceutical Calcium Antagonists Product
 Table 119. Baiyunshan Pharmaceutical Recent Developments/Updates
 Table 120. South China Pharmaceutical Group Company Information
 Table 121. South China Pharmaceutical Group Description and Business Overview
 Table 122. South China Pharmaceutical Group Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. South China Pharmaceutical Group Calcium Antagonists Product
 Table 124. South China Pharmaceutical Group Recent Developments/Updates
 Table 125. Tianjin Tanabe Seiyaku Company Information
 Table 126. Tianjin Tanabe Seiyaku Description and Business Overview
 Table 127. Tianjin Tanabe Seiyaku Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Tianjin Tanabe Seiyaku Calcium Antagonists Product
 Table 129. Tianjin Tanabe Seiyaku Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Calcium Antagonists Distributors List
 Table 133. Calcium Antagonists Customers List
 Table 134. Calcium Antagonists Market Trends
 Table 135. Calcium Antagonists Market Drivers
 Table 136. Calcium Antagonists Market Challenges
 Table 137. Calcium Antagonists Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Calcium Antagonists
 Figure 2. Global Calcium Antagonists Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Calcium Antagonists Market Share by Type: 2024 & 2031
 Figure 4. Dihydropyridine Product Picture
 Figure 5. Diltiazem Product Picture
 Figure 6. Verapamil Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Calcium Antagonists Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Calcium Antagonists Market Share by Application: 2024 & 2031
 Figure 10. Hypertension
 Figure 11. Coronary Artery Disease
 Figure 12. Arrhythmia
 Figure 13. Ohers
 Figure 14. Global Calcium Antagonists Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Calcium Antagonists Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Calcium Antagonists Sales (2020-2031) & (K Units)
 Figure 17. Global Calcium Antagonists Average Price (USD/Unit) & (2020-2031)
 Figure 18. Calcium Antagonists Report Years Considered
 Figure 19. Calcium Antagonists Sales Share by Manufacturers in 2024
 Figure 20. Global Calcium Antagonists Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Calcium Antagonists Players: Market Share by Revenue in Calcium Antagonists in 2024
 Figure 22. Calcium Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Calcium Antagonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Calcium Antagonists Sales Market Share by Country (2020-2031)
 Figure 25. North America Calcium Antagonists Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Calcium Antagonists Sales Market Share by Country (2020-2031)
 Figure 29. Europe Calcium Antagonists Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Calcium Antagonists Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Calcium Antagonists Revenue Market Share by Region (2020-2031)
 Figure 37. China Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Calcium Antagonists Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Calcium Antagonists Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Calcium Antagonists Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Calcium Antagonists Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Calcium Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Calcium Antagonists by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Calcium Antagonists by Type (2020-2031)
 Figure 59. Global Calcium Antagonists Price (USD/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Calcium Antagonists by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Calcium Antagonists by Application (2020-2031)
 Figure 62. Global Calcium Antagonists Price (USD/Unit) by Application (2020-2031)
 Figure 63. Calcium Antagonists Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Calcium Channel Antagonist Market Research Report 2024
Global Calcium Channel Blocker Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Calcium Channel Blockers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nifedipine Injection Market Research Report 2025
Global Diltiazem Hydrochloride Injection Market Research Report 2025
Global Diltiazem Calcium Channel Blocker Market Research Report 2025
Global Verapamil Calcium Channel Blocker Market Research Report 2025
Global Verapamil Market Research Report 2024
Global Calcium Channel Modulators Market Research Report 2024
Global Amlodipine Besylate Tablets Market Research Report 2024
Global Nifedipine Medication Market Research Report 2024
Global Amlodipine Market Research Report 2024
Global Felodipine Tablets Market Research Report 2025
Global Diltiazem Hydrochloride Tablets Market Research Report 2025
Diltiazem Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nilvadipine Market Research Report 2024
Global Diltiazem Hydrochloride Market Research Report 2024
Nifedipine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diltiazem Hydrochloride Extended Release Tablets Market Research Report 2025
Global Amlodipine and Olmesartan Market Insights Forecast to 2030

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions